Egyptians design 'faster, cheaper' hepatitis C test

March 14, 2012

The American University in Cairo said Wednesday that a team of its researchers has designed a faster and cheaper test for all types of hepatitis C, which it says affects about 10 million Egyptians.

The development "reduces the two-step testing process carried out over a number of days to a one-step process that takes less than an hour... at a fraction of the cost of traditional diagnostic protocols," the university said.

The liquid chemistry test can diagnose using , it said.

"Our test is sensitive and inexpensive, and it does not need sophisticated equipment," said Hassan Azzazy, professor of chemistry and head of the research team.

"Detecting HCV during the first six months raises the recovery rate to 90 percent. Little is done on the national level to combat the alarming prevalence of hepatitis C in Egypt," said Azzazy.

The AUC said Egypt has about 10 million people who suffer from the (HCV), with the blood-borne pathogen infecting almost 500,000 in the country each year.

Worldwide, around 170 million people are estimated to be living with the chronic disease caused by the virus.

Unlike hepatitis A or B, most people infected with HCV cannot shake off the virus on their own because, when under attack by the immune system, it morphs into stronger variants.

The estimates that three to four million people are newly infected with HCV each year.

The WHO says Egypt has one of the highest rates of hepatitis C prevalence in the world, putting the rate of infection in the country at 22 percent.

Contamination can occur through blood transfusions, blood products and , and the virus can also be passed on to a child if the mother is infected.

Explore further: New vaccine for hepatitis C virus

Related Stories

New vaccine for hepatitis C virus

July 28, 2011

Murdoch University researchers have begun a study to develop a new and innovative vaccine for the hepatitis C virus (HCV).

Pinpointing a tell-tale mark of liver cancer

July 8, 2011

Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related deaths. Worldwide, ...

Recommended for you

Ebola linked to habitat destruction

February 20, 2017

A Massey University veterinary scientist has co-authored research suggesting that Ebola virus emergence is linked to the clearing of animal habitat through deforestation in West and Central Africa.

Researcher helps stem the spread of superbugs

February 20, 2017

Katherine Baker feels vindicated. She and other microbiologists have been warning for years that anti-bacterial soaps containing triclosan are bad for the environment, harmful for health, and do nothing to prevent disease.

New study determines how long Zika remains in body fluids

February 20, 2017

A study published in the New England Journal of Medicine provides evidence that the Zika virus particles remain longer in blood than in urine and some other body fluids. This information suggests that blood serum may be the ...

Scientists uncover how Zika virus causes microcephaly

February 17, 2017

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered the mechanisms that the Zika virus uses to alter brain development. These findings are detailed in Stem Cell Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.